WallStSmart
ZNTL

Zentalis Pharmaceuticals Llc

NASDAQ: ZNTL · HEALTHCARE · BIOTECHNOLOGY

$4.01
+1.26% today

Updated 2026-04-30

Market cap
$287.27M
P/E ratio
P/S ratio
7.13x
EPS (TTM)
$-1.91
Dividend yield
52W range
$1 – $7
Volume
2.2M

Zentalis Pharmaceuticals Llc (ZNTL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+12.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+20.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+9.4%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$-0.49-2.2%$2.38$2.19-8.2%
2025-11-10$-0.37+30.2%$1.28$1.40+9.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.48$-0.49-2.2%
2025-09-30$-0.53$-0.37+30.2%
2025-06-30$-0.54$-0.37+31.5%
2025-03-31$-0.61$-0.67-10.4%
2024-12-31$-0.68$-0.61+10.0%$26.86M+1176.9%
2024-09-30$-0.87$-0.56+35.7%
2024-06-30$-0.84$-1.24-47.6%
2024-03-31$-0.77$0.14+118.2%$40.56M
2023-12-31$-0.92$-0.93-1.1%$2.10M
2023-09-30$-0.91$-0.79+13.2%
2023-06-30$-1.04$-1.85-77.9%
2023-03-31$-1.02$-1.07-4.9%

Frequently asked questions

Has Zentalis Pharmaceuticals Llc beaten earnings estimates?
Zentalis Pharmaceuticals Llc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +12.3% over the last 4 quarters.
How does ZNTL stock react to earnings?
ZNTL stock has moved an average of +0.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.